The Claret team were thrilled to host our annual Investor Day in April, bringing together many of our LPs, portfolio, and friends from the wider VC and growth investment community.
A huge thanks to all who joined, and in particular to those who presented and spoke on the day.
From the Claret European Growth Fund III portfolio, speakers included Eric Mayes, CEO of Endomag; Nikolai Ensslen, Founder and CEO of Synapticon; and Ranjan Singh, Co-Founder and CEO of HealthHero.
We were delighted to have three Partners from leading equity funds – Yttrium, DN Capital, and Verdane – join the afternoon panel, “Conviction in VC”. Thanks to Dirk Schmuecking, Ian Marsh, and Staffan Mörndal for sharing their insights on this theme, and what gives them conviction in deal execution, and in the entrepreneurs and businesses they back.
The afternoon concluded with our keynote speaker and independent technology analyst, Benedict Evans, who shared his extensive knowledge of everything AI.
Images from left to right, first row: Eric Mayes, CEO of Endomag; Nikolai Ensslen, Founder and CEO of Synapticon; and Ranjan Singh, Co-Founder and CEO of HealthHero.
Images from left to right, second row: Drinks reception; Panel with Antony Baker, Principal at Claret Capital Partners; Staffan Mörndal, Partner at Verdane; Dirk Schmuecking, Partner at Yttrium; and Ian Marsh, Partner at DN Capital; and keynote speaker Benedict Evans.